Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

WCT EVI MAP Mapping the Evidence for the WHO Classification of Tumours: a Living Evidence Gap Map by Tumour Type.

Coordinator
Centre International De Recherche Sur Le Cancer, France
Runs
1 July 2022 to 30 June 2026
Status
Running
EU funding
€2.8m
Total cost
€2.8m
Partners
11 organisations in 6 countries
Type
Research and Innovation Action
Grant agreement
101057127

What the project is doing

In the project's own words, from its summary on CORDIS.

The WHO Classification of Tumours (WCT) underpins cancer diagnosis, and hence treatment and care of cancer patients, as well as research into cancer epidemiology, prevention, diagnosis, and treatment. However, decisions for such a global reference tool are not always informed by the best available evidence, and risks of incorporating misinformation into the clinical decisions pathway exist. We aim to develop a tool that maps existing evidence, showing gaps, identifying pockets of low-level evidence, and synthesis of reliable evidence.

The tool will map the evidence base of the WCT in order to facilitate evidence-based decision-making in pathology, and promote the application of higher research standards in the field. We will adapt the recently developed Evidence Gap Map (EGM) methodology, first time ever to be used in biomedicine. The resulting EGMs will increase the discoverability and use of studies by the WCT decision-makers, research commissioners, researchers and others.

Our WCT-EVI-MAP project is organized in three subsequent phases, where we will apply a stepwise approach to: first, develop a framework and define evidence levels based on expert consensus; second, elaborate a series of Megamaps in iterative cycles describing evidence of all tumour types; third, perform a descriptive analysis of the use of evidence in a continuous updated exercise. To overcome identified challenges, several strategies are proposed, such as using recent advances in technologies, following a strict multidisciplinary approach and integrating this project into the WCT strategic planning for the 6th edition.

We believe that the WCT EVI-MAP will represent a ground-breaking advance for the WCT and research in the field, and will accelerate progress in cancer diagnosis and management. Integration of evidence-based medicine methods has been shown to have a positive impact in other specialized medical fields and our project represents a first step towards an evidence-based pathology.

Topics

Who is involved

OrganisationCityCountryRole
Centre International De Recherche Sur Le CancerLyon 7emeFranceCoordinator
Deutsches Herzzentrum MunchenMunichGermanyParticipant
Instituto De Salud Carlos IiiMadridSpainParticipant
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut BadawczyWarszawaPolandParticipant
Singapore Breast Surgery Center Pte. Ltd.SingaporeSGAssociatedpartner
Singapore General HospitalSingaporeSGAssociatedpartner
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner
The University of BirminghamBirminghamUnited KingdomAssociatedpartner
The University of SheffieldSheffieldUnited KingdomAssociatedpartner
University of Newcastle Upon TyneNewcastle Upon TyneUnited KingdomAssociatedpartner
University of PlymouthPlymouthUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI